ArticleSAGE open medicine2016

Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxiety.

J Douglas Thornton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.